Oncology News

March is Colorectal Cancer Awareness Month.

In a Healio video exclusive, Gerard Mullin, MD, associate professor of gastroenterology and hepatology at Johns Hopkins University, told Healio that taller adults may have an increased risk for colorectal cancer.

Fecal microbiota-based screening may help with early detection of pancreatic ductal adenocarcinoma, according to a study published in Gut.

Medical device company Medtronic and the ASGE have collaborated to create the Medtronic Health Equity Assistance Program, which aims to improve access to colorectal cancer screening technologies in underserved U.S. communities.

In patients with inflammatory bowel disease, colonoscopy within 3 years before colorectal cancer diagnosis was linked with early tumor stage detection, while colonoscopy within 1 year reduced overall all-cause mortality, according to data.

In a press room briefing, President Joseph R. Biden Jr. proclaimed March 2022 to be National Colorectal Cancer Awareness Month and announced the creation of the Advanced Research Projects Agency for Health.

A phase 3 study of acelarin in combination with cisplatin for biliary tract cancer is being discontinued at the recommendation of the study’s independent data monitoring committee, according to a press release from the agent’s manufacturer.

Celyad Oncology placed a voluntary pause on a clinical trial of CYAD-101 after two patients treated with the investigational chimeric antigen receptor T-cell therapy died.

Eating meat five times or less per week was linked to a lower overall risk for cancer, according to observational findings published in BMC Medicine.

Rare Disease Day is Feb. 28.